These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 20664519)

  • 41. Review of the role of probiotics in gastrointestinal diseases in adults.
    Sebastián Domingo JJ
    Gastroenterol Hepatol; 2017; 40(6):417-429. PubMed ID: 28185664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probiotics.
    Mizock BA
    Dis Mon; 2015 Jul; 61(7):259-90. PubMed ID: 25921792
    [No Abstract]   [Full Text] [Related]  

  • 43. Probiotics in pediatric gastrointestinal disorders.
    Davidson GP; Butler RN
    Curr Opin Pediatr; 2000 Oct; 12(5):477-81. PubMed ID: 11021414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of probiotics in gastrointestinal disease.
    Madsen KL
    Can J Gastroenterol; 2001 Dec; 15(12):817-22. PubMed ID: 11773948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics and gastrointestinal diseases.
    Sullivan A; Nord CE
    J Intern Med; 2005 Jan; 257(1):78-92. PubMed ID: 15606379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.
    Kanai T; Mikami Y; Hayashi A
    J Gastroenterol; 2015 Sep; 50(9):928-39. PubMed ID: 25940150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probiotics: their role in the treatment and prevention of disease.
    Doron S; Gorbach SL
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):261-75. PubMed ID: 16597207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
    Kang DW; Adams JB; Gregory AC; Borody T; Chittick L; Fasano A; Khoruts A; Geis E; Maldonado J; McDonough-Means S; Pollard EL; Roux S; Sadowsky MJ; Lipson KS; Sullivan MB; Caporaso JG; Krajmalnik-Brown R
    Microbiome; 2017 Jan; 5(1):10. PubMed ID: 28122648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health aspects of probiotics.
    Ouwehand A; Vesterlund S
    IDrugs; 2003 Jun; 6(6):573-80. PubMed ID: 12811680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Advances in Clinical Utility of Probiotics in Gastrointestinal Tract Disorders.
    Biswasroy P; Pradhan D; Sahu DK; Sahu A; Ghosh G; Rath G
    Curr Pharm Biotechnol; 2021; 22(12):1559-1573. PubMed ID: 33121407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.
    Johnston BC; Ma SS; Goldenberg JZ; Thorlund K; Vandvik PO; Loeb M; Guyatt GH
    Ann Intern Med; 2012 Dec; 157(12):878-88. PubMed ID: 23362517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probiotic use in clinical practice: what are the risks?
    Boyle RJ; Robins-Browne RM; Tang ML
    Am J Clin Nutr; 2006 Jun; 83(6):1256-64; quiz 1446-7. PubMed ID: 16762934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives.
    Kahouli I; Tomaro-Duchesneau C; Prakash S
    J Med Microbiol; 2013 Aug; 62(Pt 8):1107-1123. PubMed ID: 23558140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical use of probiotics in the pediatric population.
    Wallace B
    Nutr Clin Pract; 2009; 24(1):50-9. PubMed ID: 19244149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: Gut microbiota and gastrointestinal diseases: to treat or not to treat.
    Bien J; Bozko M; Malek NP; Bozko P
    Curr Pharm Des; 2014; 20(28):4533-4. PubMed ID: 24998646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.